Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma.
Heng-Wei LiuPeter Mingjui LeeOluwaseun Adebayo BamoduYu-Kai SuIat-Hang FongChi-Tai YehMing-Hsien ChienI-Hung KanChien-Min LinPublished in: Cancers (2019)
We present evidence of anti-GBM efficacy of garcinol mediated by enhancing the hsa-miR-181d/STAT3 and hsa-miR-181d/5A ratios in GBM cells. Our findings suggest a potential new therapeutic agent for combating aggressive GBM.